Pacing Characteristics of a Conventional Bipolar

NAActive, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

June 26, 2026

Conditions
Symptomatic Bradycardia
Interventions
DEVICE

Solia S lead with any BIOTRONIK Pacemaker

"* Name: Solia S lead with any BIOTRONIK Pacemaker~* Model: Solia S45/S53/S60~* Manufacturer: BIOTRONIK SE \& Co. KG~* Method of use: LBBAP implantation for all bradycardia indications.~* Mechanism of action: (1) Pacemaker stimulates the cardiac tissue to keep stable heart beats in patients with bradycardia. (2) LBBAP can be an alternative to right ventricular (RV) pacing to reduce RV pacing-induced ventricular dyssynchrony.~* Device category and grade: E3610 Cardiovascular devices, Class III"

Trial Locations (5)

10507

Chang Gung Memorial Hospital, Linkou District

Unknown

Chang Gung Memorial Hospital, Kaohsiung City

China Medical University Hospital, Taichung

MacKay Memorial Hospital, Taipei

National Yang Ming Chiao Tung University Hospital, Yilan

All Listed Sponsors
collaborator

Biotronik SE & Co. KG

INDUSTRY

lead

Chang Gung Memorial Hospital

OTHER